Microbiology

S 863390 is an antibiotic compound that inhibits the intestinal uptake system, thereby reducing the absorption of β-lactam antibiotics and small peptides. This interaction not only affects the uptake of these substances but also allows for S 863390 itself to be transported. It is valuable for research involving drug absorption and interaction studies, particularly in the context of enhancing antibiotic efficacy and understanding intestinal transport mechanisms.

Iturin A-2 is a cyclic lipopeptide antibiotic derived from Bacillus subtilis, demonstrating potent inhibitory activity against the plant pathogenic fungus Penicillium expansum with a minimal inhibitory concentration (MIC) of 8 µg/disk. This compound exhibits cytotoxic effects on various cancer cell lines, including MCF-7, BT474, and HeLa, with IC50 values of 66.81, 95.04, and 77.5 µg/mL, respectively. Additionally, Iturin A-2 effectively reduces lesion areas in southern corn leaf blight caused by Bipolaris maydis in greenhouse studies and decreases disease incidence in field studies at higher concentrations. At 12.5 µg/mL, Iturin A-2 inhibits cell division in isolated fertilized starfish eggs without affecting nuclear division.

SCH 34343 sodium is a potent β-lactam antibiotic that exhibits bactericidal activity against a broad spectrum of bacterial pathogens, including Streptococcus pneumoniae, viridans streptococci, and groups A, B, C, and G streptococci, as well as Streptococcus bovis. This compound is valuable for research applications in microbiology and infectious diseases, enabling studies on antibiotic resistance mechanisms and the efficacy of β-lactam antibiotics against clinically relevant strains.

Quinacillin is a β-lactam antibiotic that targets bacterial cell wall synthesis through irreversible covalent binding to penicillin-binding proteins. It is susceptible to hydrolysis by penicillinase, a mechanism that can diminish its efficacy against resistant strains. Quinacillin is primarily utilized in research applications aimed at understanding antibiotic resistance and the enzymatic mechanisms of β-lactamase activity. Its role in probing bacterial infections makes it a valuable reagent in microbiological studies.

Demethyl bleomycin A2 is a congener of the antibiotic Bleomycin, exhibiting strong DNA cleavage activity. It is noted for its insensitivity to 5-Methylcytidine, making it a valuable tool for research in nucleic acid interactions and cellular response mechanisms. This compound is suited for studies in cancer therapeutics and molecular biology, aiding in the exploration of DNA-targeting strategies.

Pikromycin is a macrolide antibiotic that targets bacterial protein synthesis by inhibiting RNA-dependent protein synthesis. It demonstrates significant antibacterial activity against a range of Gram-positive and Gram-negative organisms, including Escherichia coli, Staphylococcus aureus, and Bacillus subtilis. This compound is valuable for research applications in microbiology and antibiotic resistance studies.

Cefetamet hydrochloride is a cephalosporin antibiotic that exerts its antimicrobial effects by binding to bacterial penicillin-binding proteins (PBPs), with an IC50 of 2.5 μg/mL for PBP3 in Escherichia coli W3110. This compound demonstrates potent activity against a range of Gram-negative bacteria, such as Enterobacteriaceae, Neisseria species, and Haemophilus influenzae, as well as Gram-positive bacteria, including Streptococcus. Additionally, Cefetamet hydrochloride is effective in lysing Treponema pallidum. It is utilized in research focused on respiratory tract, urinary tract, ear, nose, and throat infections, as well as syphilis.

K-41 is an orally active antibiotic derived from Streptomyces hygroscopicus. This compound exhibits significant antibacterial and antiplasmodial activities, making it a valuable tool in research focused on infectious diseases. K-41 can be utilized in studies investigating potential treatments for malaria and bacterial infections, contributing to the development of new therapeutic strategies.

Deltamycin A1 is a macrolide antibiotic that exerts antibacterial activity through inhibition of bacterial protein synthesis. This compound's unique structural attributes, distinct from other macrolides, enhance its utility in microbiological research. Deltamycin A1 is valuable for studies investigating antibiotic resistance mechanisms and developing new therapeutic strategies against bacterial infections.

DRF-8417 is an oxazolidinone antibiotic that targets bacterial protein synthesis. It demonstrates significant antibacterial activity against Gram-positive and certain fastidious Gram-negative bacteria, with minimal inhibitory concentration (MIC50) and (MIC90) values ranging from 0.06 to 1 mg/L. This compound is suitable for research applications focused on combating Gram-positive infections and studying antibiotic resistance mechanisms.

Pezulepistat is a macrocyclic antibiotic that exhibits broad-spectrum activity against a variety of microbial pathogens. Its primary mechanism involves inhibiting bacterial protein synthesis, making it particularly effective against gram-negative bacterial infections. This compound is valuable for research applications focused on understanding antibiotic resistance and developing new therapeutic strategies for treating challenging infections.

Telomycin is a calcium-dependent antibiotic produced by Streptomyces species, with a primary mechanism of action that disrupts the growth of gram-positive bacteria. It demonstrates potent activity against multidrug-resistant (MDR) pathogens, making it a valuable tool for research in combating antibiotic resistance. Telomycin's unique properties position it as a critical compound for studies focused on bacterial infections and antibiotic development.

Albocycline is a macrolide antibiotic that primarily targets bacterial protein synthesis. It demonstrates potent antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA), as well as Vancomycin-intermediate (VISA) and Vancomycin-resistant Staphylococcus aureus (VRSA) strains, with minimum inhibitory concentrations (MICs) ranging from 0.5 to 1.0 μg/mL. Albocycline shows a favorable toxicity profile, exhibiting no harmful effects on human cells at concentrations of ≤64 μg/mL, making it a valuable candidate for research in antibiotic resistance studies.

Aurein 3.3 is an antimicrobial peptide with potent antibiotic properties. It exhibits a dual mechanism of action, targeting bacterial membranes and disrupting cellular integrity. Additionally, Aurein 3.3 demonstrates anticancer activity, making it a valuable resource for research into antimicrobial therapeutics and cancer biology. Its unique properties allow for diverse applications in the study of microbial resistance and cancer treatment strategies.

Enduracidin B is a polypeptide antibiotic derived from Streptomyces spp., primarily functioning by inhibiting bacterial cell wall synthesis. It exhibits potent antibacterial activity against a range of gram-positive bacteria. This compound serves as a valuable tool in antibiotic research and the study of mechanisms of resistance in pathogenic microorganisms.

Ascamycin is a 5'-O-sulfonamide ribonucleoside antibiotic derived from Streptomyces sp. JCM9888, targeting bacterial ribonucleoside metabolism. It exhibits potent selective antibacterial activity against Xanthomonas species, demonstrating minimum inhibitory concentration (MIC) values of 0.4 μg/mL for Xanthomonas citri, 12.5 μg/mL for Xanthomonas oryzae, and 12.5 μg/mL for Mycobacterium phlei. This compound serves as a valuable tool for research applications focused on bacterial infections and antibiotic resistance mechanisms.

(E)-Aztreonam is a monocyclic beta-lactam antibiotic that specifically targets bacterial cell wall synthesis. It exhibits significant antimicrobial activity against gram-negative pathogens, making it a valuable compound for the study of infections caused by these organisms. This reagent is ideal for research applications focused on antibiotic resistance, mechanism of action studies, and the development of new antimicrobial therapies.

PD 116152 is a phenazine antibiotic that exhibits both antimicrobial and antitumor properties. It demonstrates significant cytotoxic activity against L1210 lymphocytic leukemia and human colon adenocarcinoma (HCT-8) cells, with IC50 values of 5.2 x 10-7 M and 7.1 x 10-7 M, respectively. This compound offers potential for research applications in the study of P388 lymphocytic leukemia.

Teicoplanin sodium is a glycopeptide antibiotic primarily targeting Gram-positive bacteria. It is indicated for the treatment of serious infections caused by organisms such as Methicillin-resistant Staphylococcus aureus (MRSA) and Enterococcus faecalis. Additionally, Teicoplanin sodium exhibits antiviral activity against HIV-1, SARS-CoV-1, and SARS-CoV-2, making it a versatile agent in research applications focused on antimicrobial and antiviral efficacy.

(4-Aminobenzyl)phosphonic acid is a bioactive compound that acts as a bacterial inhibitor. It exhibits notable antibacterial and potential anticancer activities, making it useful in various research applications, particularly in the synthesis of new compounds aimed at inhibiting bacterial growth. Its unique structural properties enable effective interaction with biological targets, facilitating the exploration of novel therapeutic strategies.

Spectinomycin is an antibiotic that primarily targets bacterial ribosomes to inhibit protein synthesis. It exhibits broad-spectrum activity against various gram-positive and gram-negative organisms. Additionally, spectinomycin functions as a noncompetitive inhibitor of td intron RNA, making it a useful tool in studies of bacterial physiology and genetic regulation. Its applications extend to microbiological research and the exploration of antibiotic resistance mechanisms.

Bacillosporin C is an oxaphenalenone dimer that acts as a potent antibiotic. Isolated from the bacterium T. bacillosporus and derived from the lactone bacillosporin D found in the mangrove endophytic fungus SBE-14, Bacillosporin C demonstrates significant antibacterial properties. Additionally, it has been shown to inhibit acetylcholinesterase, making it a valuable tool for research in microbial resistance and neuropharmacology.

Corynecin III is an antibiotic derived from Corynebacterium that functions similarly to Chloramphenicol. It exhibits broad-spectrum antibacterial activity against both Gram-positive and Gram-negative bacteria, demonstrating minimum inhibitory concentrations (MIC) ranging from 2.6 to 83 μg/mL. This compound is valuable in research applications focused on antibiotic resistance and the development of new therapeutic agents.

Lavendomycin is a peptide antibiotic derived from Streptomyces that primarily targets Gram-positive bacteria. It exerts its antibacterial activity by disrupting bacterial protein synthesis, making it a valuable tool for research on antibiotic resistance and bacterial infections. Lavendomycin's efficacy against a range of Gram-positive pathogens highlights its potential applications in microbiological studies and therapeutic development.

Mandelonitrile benzoate is an antibiotic compound primarily derived from the defensive secretions of millipedes. This reagent exhibits notable biological activity against various pathogens, suggesting potential application in antimicrobial research. In addition to its antibiotic properties, mandelonitrile benzoate plays a role in the cyanidation process, releasing hydrocyanic acid and benzaldehyde. Its unique chemical profile contributes to the understanding of chemical defenses in millipedes, serving as a valuable tool in studying antipredator mechanisms and the chemotaxonomy of these organisms.

Aldgamycin E is a neutral macrolide antibiotic derived from the culture filtrates of Streptomyces lavendulae. It exhibits significant antibacterial activity against various Gram-positive bacteria. This compound is utilized in microbiological studies for elucidating antibiotic mechanisms and assessing microbial resistance.

Malonomicin is an antibiotic that primarily targets bacterial and protozoan pathogens. It exhibits notable anti-protozoa and anti-trypanosome activities, demonstrating efficacy in both in vitro and in vivo models against Trypanosoma species. This compound is valuable for research in infectious disease mechanisms and the development of novel therapeutics for protozoan infections.

Epopromycin A is a potent antibiotic that disrupts cell wall synthesis in lettuce protoplasts, demonstrating significant herbicidal activity. Additionally, it exhibits notable cytotoxic effects against B16 melanoma cells, with an IC50 value of 0.003 µg/mL. This compound may be utilized in research applications focused on plant pathology and cancer therapeutics.

(4S,5S,6S,12aS)-Oxytetracycline is a broad-spectrum antibiotic that targets bacterial protein synthesis by inhibiting ribosomal translation. This compound is a significant member of the bacterial aromatic polyketone family, exhibiting various biological activities. It is commonly utilized in research to study antibiotic mechanisms and bacterial resistance, as well as to explore the role of protein synthesis in microbial physiology.

Azlocillin is a semisynthetic penicillin antibiotic that acts primarily by inhibiting bacterial cell wall synthesis. This compound exhibits broad-spectrum antibacterial activity, making it effective against a variety of gram-positive and gram-negative bacteria. Notably, Azlocillin demonstrates activity against drug-tolerant Borrelia burgdorferi sensu stricto JLB31, thus serving as a valuable tool in research focused on antibiotic resistance and Lyme disease.

Garenoxacin mesylate is an orally active quinolone antibiotic that targets DNA gyrase and topoisomerase IV. It exhibits a broad spectrum of antibacterial activity against both gram-positive and gram-negative bacteria, as well as anaerobic organisms. This compound is utilized in research applications focusing on antibacterial efficacy and resistance mechanisms.

11-Demethyltomaymycin is an antibiotic that exhibits potent antiviral activity against Escherichia coli T1 and T3 phages, as well as antibacterial effects against Gram-positive bacterial strains. Additionally, this compound demonstrates cytotoxicity against leukemia L1210 cells, making it a valuable tool in cancer research and microbiological studies. Its multifaceted biological activity supports its potential applications in both therapeutic development and mechanistic studies of bacterial and viral infections.

Arizonin B1 is an antibiotic compound primarily targeting Gram-positive bacteria. Derived from microbial sources, it exhibits significant antibacterial activity, making it a valuable tool for research in microbial resistance and antibiotic efficacy. Its application extends to studies focusing on the mechanisms of action against pathogenic strains, contributing to the development of new therapeutic strategies.

Mupirocin calcium is an orally active antibacterial agent derived from Pseudomonas fluorescens. It primarily functions by reversibly inhibiting isoleucyl-transfer RNA, which disrupts bacterial protein and RNA synthesis, leading to effective antimicrobial activity. This compound is utilized in research applications aimed at studying bacterial resistance mechanisms and the development of new antibacterial therapies.

LY164846 is an orally active cephalosporin antibiotic that primarily targets Haemophilus influenzae, exhibiting high sensitivity to both typical and ampicillin-resistant strains, with an MIC90 ≤ 4 μg/mL. The compound also demonstrates significant activity against Methicillin-resistant Staphylococcus aureus and Streptococcus species (excluding Enterococcus), with MIC90 values ranging from 0.25 to 8 μg/mL, and shows moderate sensitivity towards anaerobic bacteria. Its bactericidal properties are indicated by an MBC/MIC ratio of ≤ 2 against Haemophilus influenzae. LY164846 is valuable for investigating respiratory and skin infections in biomedical research.

Alahopcin is a dipeptide antibiotic that exerts its activity by inhibiting bacterial protein synthesis. It demonstrates a broad spectrum of antibacterial efficacy, making it useful for research applications in microbiology and infectious disease studies. Its unique mechanism of action allows for exploration of antibiotic resistance and the development of new therapeutic strategies.

Phospholine is an antibiotic that targets bacterial growth and proliferation. It demonstrates potent cytotoxic activity, with IC50 values of 3.37 μg/mL for Ll 210 cells, 2.20 μg/mL for P388 cells, and 1.99 μg/mL for EL-4 cells. This compound is applicable in research settings focused on antimicrobial resistance and the development of novel therapeutic strategies.

YM-17K is a macrolide antibiotic that targets bacterial cell function. It demonstrates broad-spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria as well as anaerobic bacteria. With stable activity in serum and reduced sensitivity to pH fluctuations, YM-17K is valuable for research applications in microbiology and antibiotic resistance studies.

MGB-BP-3 is a bacterial inhibitor that targets multi-resistant Gram-positive pathogens. This antibiotic exhibits potent activity across a variety of clinically relevant bacterial strains, making it a valuable tool for studies focused on combating antibiotic resistance. Its broad-spectrum efficacy supports research applications in antibiotic development and microbiology.

Rubiginone D2 is an antibiotic known for its antimicrobial activity against Bacillus subtilis, Staphylococcus aureus, and Escherichia coli. In addition to its antibacterial properties, Rubiginone D2 demonstrates significant antitumor efficacy, inhibiting the proliferation of various cancer cell lines, including HM02, Kato III, HepG2, and MCF7, with GI50 values of 0.1, 0.7, less than 0.1, and 7.5 μM, respectively. This compound is valuable for research on antibiotic resistance and cancer therapeutics.

Amicetin is a potent antibiotic that primarily targets bacterial protein synthesis. Demonstrating significant activity against gram-positive bacteria, Amicetin effectively disrupts cellular processes essential for bacterial growth and replication. This compound is valuable for research applications focused on elucidating antibiotic mechanisms and developing new therapeutic strategies against resistant bacterial strains.

Martinomycin is an antibiotic that targets bacterial infections by inhibiting the growth of Staphylococcus spp., Streptococcus spp., and Enterococcus spp. It demonstrates a minimum inhibitory concentration (MIC) range of 0.06 to 0.5 μg/mL, indicating potent antibacterial activity. This compound is valuable in microbiological studies and research focused on antibiotic resistance mechanisms.

PF-945863 is an orally active macrolide antibiotic that targets bacterial ribosomes, thereby inhibiting protein synthesis. This compound demonstrates significant efficacy against multidrug-resistant respiratory tract bacterial strains, making it a valuable tool for research in combating antibiotic resistance. Its application extends to studies aimed at understanding bacterial resistance mechanisms and developing new therapeutic strategies.

Diastovaricin I, a derivative of naphthomycin, functions primarily as an antibiotic. It is notable for its ability to induce differentiation in mouse Friend cells, making it a valuable tool for studies in cell biology and differentiation processes. Its unique mechanism and biological activity position it as a potential reagent for research involving cellular development and related applications.

Cefalonium dihydrate is a cephalosporin antibiotic with a primary action against Staphylococcus aureus. This compound exhibits both antibacterial and anti-inflammatory properties, making it a valuable reagent in the study of bacterial infections and inflammation-related research. Cefalonium dihydrate is suitable for applications in microbiology and pharmacology, providing insights into antibiotic efficacy and therapeutic development.

Mezlocillin is a β-lactam antibiotic with a semisynthetic structure and extended-spectrum activity. It demonstrates efficacy against a wide range of both gram-negative and gram-positive bacteria. Mezlocillin is suitable for research applications focused on bacterial infections and the investigation of antibiotic resistance mechanisms.

Posizolid (AZD2563) is an oxazolidinone antibiotic designed for the treatment of bacterial infections. This compound exhibits potent anti-mycobacterial activity, making it a valuable tool in research focused on mycobacterial diseases, including tuberculosis. Its mechanism of action involves inhibition of protein synthesis, targeting the bacterial ribosome.

Leucomycin tartrate is a potent 16-membered macrolide antibiotic that primarily targets bacterial protein synthesis. It exhibits strong antibacterial activity against a range of Gram-positive organisms, making it useful in research applications focused on antimicrobial resistance and the mechanisms of action of antibiotics. This compound is instrumental for studies investigating bacterial infections and developing novel therapeutic strategies.

Armeniaspirol B is a selective antibiotic that primarily targets Gram-positive pathogens. It exhibits minimal inhibitory concentration (MIC) values of 0.5 μg/mL against Staphylococcus aureus Newman and 2.0 μg/mL against Staphylococcus aureus USA300. This compound is of particular interest for research focused on Gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) infections.

Valnemulin is a broad-spectrum antibacterial agent with efficacy against both Gram-positive and Gram-negative bacteria, as well as anaerobic bacteria, Mycoplasma, and Spirochetes. It is primarily utilized in veterinary medicine to treat enteric diseases, acute polyarthritis, and enzootic pneumonia in swine. Additionally, Valnemulin demonstrates anti-inflammatory properties, effectively mitigating lipopolysaccharide-induced lung injury in experimental models.